| HOME >> BIOLOGY >> TECHNOLOGY |
Exercise of stock options 81,242 167,914
Proceeds from long-term debt 250,000 777,811
Repayment of long-term debt (704,990) (612,938)
Repayment of repayable advances (85,640) -
------------ ------------
22,649,546 312,503
Investing activities
Proceeds on sale of property and equipment 6,000 7,000
Acquisition of property and equipment (5,599,035) (1,410,000)
------------ ------------
(5,593,035) (1,403,000)
------------ ------------
Increase (decrease) in
cash and cash equivalents 4,115,554 (12,184,636)
Cash and cash equivalents - Beginning of year 16,328,459 28,513,095
------------ ------------
Cash and cash equivalents - End of year 20,444,013 16,328,459
------------ ------------
------------ ------------
Supplemental Information
Cash interest received 1,367,372 444,063
Cash interest paid 175,343 167,026
Non-cash transactions
Capital items included in accounts payable 276,373 362,608
Share issue costs included in accounts payable 57,884 -
Proceeds from issuance of common
shares included in accounts receivable - 4,186
'/>"/>
| SOURCE SemBioSys Genetics Inc. Copyright©2008 PR Newswire. All rights reserved |